Adverum Biotechnologies, Inc. - stock earnings
ADVM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -23.7 million USD | ? USD |
| 2023Q3 | -32.9 million USD | ? USD |
| 2023Q2 | -31.5 million USD | ? USD |
| 2023Q1 | -29.1 million USD | 3.6 million USD |
| 2022Q4 | -32.7 million USD | ? USD |
| 2022Q3 | -40.1 million USD | ? USD |
| 2022Q2 | -43.8 million USD | ? USD |
| 2022Q1 | -37.9 million USD | ? USD |
| 2021Q4 | -34.4 million USD | -7.5 million USD |
| 2021Q3 | -38.4 million USD | ? USD |
| 2021Q2 | -44.3 million USD | ? USD |
| 2021Q1 | -28.4 million USD | 7.5 million USD |
| 2020Q4 | -37.6 million USD | ? USD |
| 2020Q3 | -27.8 million USD | ? USD |
| 2020Q2 | -29.2 million USD | ? USD |
| 2020Q1 | -22.9 million USD | ? USD |
| 2019Q4 | -18.9 million USD | -250000 USD |
| 2019Q3 | -16.1 million USD | 250000 USD |
| 2019Q2 | -15.0 million USD | ? USD |
| 2019Q1 | -14.5 million USD | 70000 USD |
| 2018Q4 | -15.7 million USD | 70000 USD |
| 2018Q3 | -21.0 million USD | 833000 USD |
| 2018Q2 | -18.8 million USD | 493000 USD |
| 2018Q1 | -17.2 million USD | 216000 USD |
| 2017Q4 | -14.8 million USD | 461000 USD |
| 2017Q3 | -13.8 million USD | 463000 USD |
| 2017Q2 | -11.4 million USD | 463000 USD |
| 2017Q1 | -16.1 million USD | 462000 USD |
| 2016Q4 | -22.4 million USD | 488000 USD |
| 2016Q3 | -14.3 million USD | 395000 USD |
| 2016Q2 | -61.7 million USD | 307000 USD |
| 2016Q1 | -15.4 million USD | 265000 USD |
| 2015Q4 | -14.1 million USD | 960000 USD |
| 2015Q3 | -14.1 million USD | 953000 USD |
| 2015Q2 | -9.8 million USD | 203000 USD |
| 2015Q1 | -9.5 million USD | 203000 USD |
| 2014Q4 | -10.4 million USD | 203000 USD |
| 2014Q3 | -8.3 million USD | 204000 USD |
| 2014Q2 | -5.1 million USD | 135000 USD |
| 2014Q1 | -1.7 million USD | 30000 USD |
| 2013Q4 | -3.7 million USD | 450000 USD |
| 2013Q3 | -813000 USD | 30000 USD |
| 2013Q2 | -721000 USD | 150000 USD |
| 2013Q1 | -49000 USD | 300000 USD |
| 2012Q4 | ? USD | 30000 USD |
ADVM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -117.2 million USD | 3.6 million USD |
| 2022 | -154.5 million USD | 3.6 million USD |
| 2021 | -145.5 million USD | 7.5 million USD |
| 2020 | -117.5 million USD | 7.5 million USD |
| 2019 | -64.5 million USD | 250000 USD |
| 2018 | -72.6 million USD | 1.6 million USD |
| 2017 | -56.1 million USD | 1.8 million USD |
| 2016 | -113.7 million USD | 1.5 million USD |
| 2015 | -47.5 million USD | 2.3 million USD |
| 2014 | -25.4 million USD | 572000 USD |
| 2013 | -5.3 million USD | 480000 USD |
| 2012 | -1.8 million USD | 30000 USD |
ADVM
Price: $10
52 week price:
Earnings Per Share: -11.60 USD
P/E Ratio: -1.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 198800
Ebitda: -14.0 millionMarket Capitalization: 248.5 million